PubRank

S K Sarin

Author PubWeight™ 106.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol 2013 3.19
2 Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: surgical management. Br J Surg 1998 2.07
3 A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 2007 2.07
4 Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007 1.88
5 Endoscopic sclerotherapy using absolute alcohol. Gut 1985 1.73
6 Frequency and clinical profile of precore and surface hepatitis B mutants in Asian-Indian patients with chronic liver disease. Am J Gastroenterol 1996 1.70
7 Blood transfusion practices in India: results of a national survey. Indian J Gastroenterol 2000 1.70
8 Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. Indian J Gastroenterol 2001 1.67
9 P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India. Cancer 2000 1.63
10 Coagulation profile and platelet function in patients with extrahepatic portal vein obstruction and non-cirrhotic portal fibrosis. J Gastroenterol Hepatol 2001 1.52
11 Portal biliopathy. J Gastroenterol Hepatol 2001 1.51
12 The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients. Aliment Pharmacol Ther 2010 1.50
13 Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. J Viral Hepat 2013 1.46
14 What is safe blood? J Assoc Physicians India 2000 1.45
15 High seroprevalence and clinical significance of hepatitis B and C infection in hospitalized patients with alcoholic cirrhosis. J Assoc Physicians India 2002 1.39
16 Recombinant interferon therapy in Indian children with HBV related chronic liver disease. Indian Pediatr 2002 1.39
17 Endoscopic biliary drainage by nasobiliary drain or by stent placement in patients with acute cholangitis. Endoscopy 2005 1.39
18 Inferior vena caval obstruction due to amoebic liver abscess. J Assoc Physicians India 1982 1.33
19 Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis. J Hepatol 2000 1.32
20 Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis. J Viral Hepat 2012 1.21
21 Role of HBV genotype in predicting response to lamivudine therapy in patients with chronic hepatitis B. Indian J Gastroenterol 2005 1.20
22 Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther 2009 1.19
23 Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study. Gut 1986 1.16
24 A case report of olanzapine-induced fecal incontinence. J Clin Psychiatry 2003 1.10
25 Acute pancreatitis associated with viral hepatitis: a report of six cases with review of literature. Am J Gastroenterol 1999 1.09
26 Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis. Gut 1987 1.08
27 The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology 1995 1.08
28 Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat 2013 1.07
29 A case of hepatocellular carcinoma associated with troublesome hypoglycemia: management by cytoreduction using percutaneous ethanol injection. Am J Gastroenterol 1998 1.07
30 Balloon tamponade in the management of bleeding oesophageal varices. Ann R Coll Surg Engl 1984 1.06
31 Choledochal cysts--differences in children and adults. Br J Surg 1996 1.06
32 Endoscopic management of liver abscesses and cysts that communicate with intrahepatic bile ducts. Endoscopy 2006 1.05
33 Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status. Dig Dis Sci 2006 1.04
34 Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients. J Viral Hepat 1999 1.03
35 NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx. Oncogene 2009 1.01
36 Pattern of alcohol-related liver disease in dependent alcoholics: the Indian dimension. Br J Addict 1988 1.01
37 Choledocholithiasis associated with portal biliopathy in patients with extrahepatic portal vein obstruction: management with endoscopic sphincterotomy. Gastrointest Endosc 1995 0.99
38 Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter? J Assoc Physicians India 2002 0.98
39 Do umbilical vein catheterization and sepsis lead to portal vein thrombosis? A prospective, clinical, and sonographic evaluation. J Pediatr Gastroenterol Nutr 1993 0.98
40 Repeated endoscopic sclerotherapy for active variceal bleeding. Ann Surg 1985 0.98
41 Corrosive oesophageal strictures following acid ingestion: clinical profile and results of endoscopic dilatation. J Gastroenterol Hepatol 1991 0.98
42 Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM 2008 0.96
43 Hepatic dysfunction in patients with extrahepatic portal venous obstruction. Liver Int 2003 0.96
44 Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report. J Gastroenterol Hepatol 2001 0.95
45 Follow-up of patients after variceal eradication. A comparison of patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction. Ann Surg 1986 0.95
46 Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial. Gut 1987 0.93
47 A clinico-radiological reappraisal of intestinal tuberculosis--changing profile? Gastroenterol Jpn 1986 0.93
48 Hepatic manifestations in typhoid fever. Indian Pediatr 1994 0.92
49 Endoscopic management of bile leaks after blunt abdominal trauma. J Gastroenterol Hepatol 2008 0.92
50 Cholesterol and pigment gallstones in northern India. A prospective analysis. Dig Dis Sci 1986 0.91
51 Transfusion associated hepatitis: the Indian scenario. Indian Pediatr 1997 0.90
52 Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices. Aliment Pharmacol Ther 2009 0.89
53 Absence of hemochromatosis associated Cys282Tyr HFE gene mutation and low frequency of hemochromatosis phenotype in nonalcoholic chronic liver disease patients in India. J Gastroenterol Hepatol 2004 0.89
54 Propofol sedation during endoscopy in patients with cirrhosis, and utility of psychometric tests and critical flicker frequency in assessment of recovery from sedation. Endoscopy 2011 0.89
55 Hepatic visceral larva migrans: evolution of the lesion, diagnosis, and role of high-dose albendazole therapy. Am J Gastroenterol 1994 0.89
56 Autoimmune hepatitis in the Indian subcontinent: 7 years experience. J Gastroenterol Hepatol 2001 0.88
57 Ulcerative colitis in a North Indian hospital: current trends. J R Coll Physicians Lond 1985 0.88
58 Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach. Am J Gastroenterol 1989 0.88
59 Transfusion-associated hepatitis in a tertiary referral hospital in India. A prospective study. Vox Sang 1999 0.87
60 Is cirrhosis of the liver reversible? Indian J Pediatr 2007 0.86
61 Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci 1987 0.86
62 Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients. Hepatol Int 2010 0.86
63 Subclinical encephalopathy after portosystemic shunts in patients with non-cirrhotic portal fibrosis. Liver 1985 0.85
64 Histological subclassification of cirrhosis based on histological-haemodynamic correlation. Aliment Pharmacol Ther 2008 0.85
65 Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight. Gut 1987 0.85
66 Identification of a novel surface mutant of hepatitis B virus in a seronegative chronic liver disease patient. Virus Res 1999 0.84
67 Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. J Gastroenterol Hepatol 1999 0.84
68 Endoscopic biliary drainage by 7 Fr or 10 Fr stent placement in patients with acute cholangitis. Dig Dis Sci 2008 0.83
69 Rabbit model of non-cirrhotic portal fibrosis with repeated immunosensitization by rabbit splenic extract. J Gastroenterol Hepatol 2002 0.82
70 Oesophageal ulceration after sclerotherapy--a complication or an accompaniment? Endoscopy 1986 0.82
71 Gastric secretion in cirrhosis and non-cirrhotic portal fibrosis. Digestion 1988 0.81
72 Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B: a cross-sectional study. Indian J Med Microbiol 2012 0.80
73 Polymerase chain reaction based diagnostic assay for identification of hepatitis B virus. Indian J Med Res 1992 0.80
74 Increased regulatory T cells and impaired functions of circulating CD8 T lymphocytes is associated with viral persistence in Hepatitis B virus-positive newborns. J Viral Hepat 2013 0.80
75 Studies on TAQ1 polymorphism in the 3'untranslated region of IL-12P40 gene in HCV patients infected predominantly with genotype 3. J Med Virol 2006 0.80
76 Feasibility spectrum for Doppler flowmetry of splanchnic vessels. In normal and cirrhotic populations. J Ultrasound Med 1990 0.79
77 Low-dose recombinant interferon therapy in anti-HBe-positive chronic hepatitis B in Asian Indians. J Gastroenterol Hepatol 1998 0.79
78 Prevention of first variceal bleed: an appraisal of current therapies. Am J Gastroenterol 1998 0.79
79 Possible HLA influence in governing susceptibility to non-cirrhotic portal fibrosis. Tissue Antigens 1987 0.79
80 Amoebic liver abscess in a North Indian hospital--current trends. Br J Clin Pract 1987 0.79
81 Prevalence of hepatitis GB virus C/hepatitis G virus infection in blood donors in India. J Assoc Physicians India 2000 0.79
82 Diaphragm disease of duodenum following long-term NSAIDs use: endoscopic management. Indian J Gastroenterol 2004 0.79
83 Carcinoid tumour of ampulla of Vater associated with viscero-cutaneous neurofibromatosis. Postgrad Med J 1983 0.78
84 Cholestatic liver injury due to ibuprofen. Indian J Gastroenterol 2005 0.78
85 Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3. J Viral Hepat 2012 0.78
86 Systematic review: combination therapies for treatment-naïve chronic hepatitis B. Aliment Pharmacol Ther 2008 0.78
87 Biliary lipid composition in patients with non-cirrhotic portal fibrosis--a comparison with compensated cirrhosis of the liver. Liver 1987 0.78
88 Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients. Hepatol Int 2009 0.78
89 Histological comparison of chronic hepatitis B and C in an Indian population. Trop Gastroenterol 2000 0.78
90 Hepatic Sarcoidosis: Clinico-pathological characterization of symptomatic cases. Acta Gastroenterol Belg 2015 0.77
91 Characterization of peripheral blood lymphocytes in patients with non-cirrhotic portal fibrosis: a comparison with cirrhotics and healthy controls. J Gastroenterol Hepatol 1991 0.77
92 Relevance of hepatitis B surface antigen levels in patients with chronic hepatitis B during 5 year of tenofovir treatment. J Viral Hepat 2013 0.77
93 Measuring hepatic functional reserve using MEGX: still a mirage! Indian J Gastroenterol 2008 0.77
94 Do chillies influence healing of duodenal ulcer? Br Med J (Clin Res Ed) 1984 0.77
95 Noncompressive myelopathy after lienorenal shunt in a patient with noncirrhotic portal fibrosis. Am J Gastroenterol 1983 0.77
96 Profile of asymptomatic chronic HBV infection in India. Indian J Med Res 2002 0.77
97 Profile of chronic hepatitis B virus in children in India: experience with 116 children. J Gastroenterol Hepatol 2006 0.76
98 Beneficial influence of an indigenous low-iron diet on serum indicators of iron status in patients with chronic liver disease. Br J Nutr 2000 0.76
99 The frequency and influence of gallbladder varices on gallbladder functions in patients with portal hypertension. Am J Gastroenterol 1995 0.76
100 Clinical trial on the effect of domperidone on non-ulcer dyspepsia. Indian J Med Res 1986 0.76
101 Fine needle aspiration cytologic appearance of inflammatory pseudotumor of the liver. A case report. Acta Cytol 1999 0.76
102 Ulceration after esophageal and gastric variceal sclerotherapy--influence of sucralfate and other factors on healing. Endoscopy 1988 0.75
103 Left lobe amoebic abscess of liver--a distinct clinical entity. J Assoc Physicians India 1984 0.75
104 Correlation between two chemiluminescence based assays for quantification of hepatitis B surface antigen in patients with chronic hepatitis B infection. Indian J Med Microbiol 2015 0.75
105 Endoscopic ligation plus sclerotherapy: two plus two make only three! Gastrointest Endosc 1999 0.75
106 Multimodality imaging of obliterative portal venopathy: what every radiologist should know. Br J Radiol 2014 0.75
107 Interferon in chronic hepatitis B. J Assoc Physicians India 1993 0.75
108 Therapeutic guidelines for subacute hepatic failure. Indian J Gastroenterol 1993 0.75
109 Splenoportovenography: safety, success rate and hemodynamic changes, and incidence and natural history of splenic hematoma. Indian J Gastroenterol 1991 0.75
110 Pathophysiology of portal hypertension. J Gastroenterol Hepatol 2002 0.75
111 Noradrenaline in upper gastrointestinal haemorrhage. A prospective, randomized, double blind controlled clinical trial. Trop Doct 1984 0.75
112 Base-pair alterations in the epsilon-lower stem due to a novel double substitution in the precore gene of HBV-e negative variant were recovered by secondary mutations. Virus Genes 2001 0.75
113 Hepatorenal syndrome: current perspectives. J Assoc Physicians India 1996 0.75
114 Familial prevalence of gallstone in first-degree relatives of patients with gallstones. Hepatology 1996 0.75
115 Pyoderma gangrenosum in ulcerative colitis. J Assoc Physicians India 1991 0.75
116 Effects of intravenous nitroglycerin and metoclopramide on intravariceal pressure: a double-blind, randomized study. Am J Gastroenterol 1993 0.75
117 Role of endoscopic retrograde cholangiopancreatography (ERCP) in patients with post cholecystectomy problems. Indian J Gastroenterol 1987 0.75
118 Incidence of hepatitis B surface antigen (HBsAg) in and around Delhi. J Commun Dis 1986 0.75
119 Thyroid hormones in liver diseases. Indian J Med Res 1983 0.75
120 Interferon therapy in chronic viral hepatitis. J Assoc Physicians India 1995 0.75
121 Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma. Trop Gastroenterol 1998 0.75
122 Medical treatment of oesophageal varices. J Assoc Physicians India 1986 0.75
123 Alpha-fetoprotein production by non-hepatocellular carcinoma, malignant liver tumor. Indian J Cancer 2009 0.75
124 Non-operative management of portal hypertension and oesophageal varices. Trop Gastroenterol 1986 0.75
125 Primary amyloidosis of the gut. J Indian Med Assoc 1984 0.75
126 Injection sclerotherapy for varices. Trop Gastroenterol 1988 0.75
127 Treatment of variceal bleeding in the '90s. Indian J Gastroenterol 1993 0.75
128 Primary lymphomas of the gastrointestinal tract. Trop Gastroenterol 1983 0.75
129 Enhanced immunogenicity of recombinant hepatitis B vaccine in exposed family contacts of chronic liver disease patients. Scand J Infect Dis 2001 0.75
130 Clinical differentiation of upper gastrointestinal bleeding. Indian J Gastroenterol 1986 0.75
131 Clinical implications of viral activity in dual infection with hepatitis B and C in chronic liver disease. J Assoc Physicians India 2002 0.75
132 Management protocols for hepatitis B. Indian J Gastroenterol 2001 0.75
133 Echodoppler flowmetry. Principle and application in abdominal diseases. J Assoc Physicians India 1989 0.75
134 Ulcers after intravariceal sclerotherapy: correlation of symptoms and factors affecting healing. J Clin Gastroenterol 1990 0.75
135 Evaluation of parameters of cure in amoebic liver abscess. J Assoc Physicians India 1983 0.75
136 Effects of sucralfate on gastric acid secretion and duodenal ulcer healing. J Assoc Physicians India 1988 0.75
137 Hepatobiliary and pancreatic: simple pancreatic cysts. J Gastroenterol Hepatol 2005 0.75
138 Iron and liver: current concepts in the pathogenesis and management of chronic liver diseases. J Assoc Physicians India 1996 0.75
139 Sclerotherapy for variceal bleeding in children. Indian Pediatr 1988 0.75
140 Caroli disease: computed tomographic diagnosis. Gastrointest Radiol 1991 0.75
141 Comparative evaluation of visual, somatosensory, and auditory evoked potentials in the detection of subclinical hepatic encephalopathy in patients with nonalcoholic cirrhosis. Am J Gastroenterol 1990 0.75
142 Primary miliary tuberculosis of the liver. J Assoc Physicians India 1984 0.75
143 Hepatic venous pressure gradient in cirrhosis: role in variceal bleeding, non-bleeding complications and outcome. Asian J Surg 2006 0.75
144 Bacteremia & pyrexia following sclerotherapy with alcohol. Indian J Med Res 1987 0.75
145 Liver in heroin smokers. J Assoc Physicians India 1987 0.75
146 Diet and duodenal ulcer. J Assoc Physicians India 1985 0.75